Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Sodium Ferric Gluconate Complex in TAVI patients
NCT04797832Phase 4Unknown
- Sponsor
- Rambam Health Care Campus
- Start
- Oct 2020
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sodium ferric gluconate in iron deficiency anemia (IDA) (2 arms), sponsored by Rambam Health Care Campus. Primary endpoint: 6-minute walk change at 1 month. Status: unknown.
02
Drugs
sodium ferric gluconate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT04797832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04797832.